Primary sclerosing cholangitis (PSC) care
Long-term care for a condition that scars the bile ducts inside and outside the liver, where there is no proven medicine to stop it, so care focuses on monitoring, managing symptoms and complications, and considering transplant.
✓ Medically reviewed by a GMC-registered consultant · last reviewed September 2026 · next review September 2027 · how we review
In short
- PSC scars the bile ducts; there is no medicine proven to stop it, so care centres on monitoring and managing problems.
- It is strongly linked to inflammatory bowel disease, and people with colitis need regular bowel-cancer surveillance.
- PSC raises the risk of bile duct cancer, so surveillance and prompt investigation of changes matter.
- A liver transplant is the only treatment that can cure the liver disease, though PSC can sometimes return afterwards.
A plain-English summary. The detail — including risks and recovery — is below.
At a glance
A general guide. Your specialist will give you advice for your situation.
Regular surveillance can catch bile duct, bowel or gallbladder cancer earlier.
High-dose ursodeoxycholic acid is not recommended as routine treatment for PSC, and high doses have been linked to harm.
Imaging (often MRCP) and blood tests establish the picture. You are usually linked to a specialist liver centre and a surveillance plan is set up.
A clear, written surveillance plan covering blood tests, bile duct imaging and (with colitis) colonoscopy.
Imaging (often MRCP) and blood tests establish the picture. You are usually linked to a specialist liver centre...
Regular blood tests and imaging track the disease, with colonoscopy surveillance if you have inflammatory bowel...
A dominant bile duct narrowing may be treated with ERCP; infections are treated with antibiotics; symptoms are...
Some people are referred for liver transplant assessment, the only treatment that can cure the liver disease.

What is primary sclerosing cholangitis (PSC) care?
Primary sclerosing cholangitis (PSC) is an uncommon, long-term condition in which the bile ducts inside and outside the liver become inflamed and scarred, narrowing over time. This can slow the flow of bile and, over years, lead to liver damage. PSC is strongly linked to inflammatory bowel disease, especially ulcerative colitis.
Unlike some other liver conditions, there is currently no medicine proven to stop PSC or reliably slow it down. So care focuses on three things: watching the disease and its complications closely, treating symptoms such as itching and tiredness, and acting on problems like blocked bile ducts or infections when they arise.
Because PSC carries a raised risk of bile duct cancer, bowel cancer (especially with colitis) and other complications, surveillance is an important part of care. For some people, a liver transplant becomes the only treatment that can cure the liver disease.
This guide explains what good long-term care looks like and what to ask. It is general information, not personal medical advice; your liver specialist will tailor your plan.
Types, options & approaches
There may be different ways to do this. The right approach depends on the clinical question and your circumstances.
What care can and cannot do in PSC
| Aim | Reality |
|---|---|
| Stop or reverse the disease | No medicine reliably does this yet |
| Ease symptoms (itch, tiredness) | Often possible |
| Open a blocked bile duct | Possible with ERCP |
| Cure the liver disease | Only a liver transplant can |
Because there is no proven disease-slowing medicine, surveillance and managing complications are central.
Preparing for your treatment
- Tell your clinician if you have, or have ever had, inflammatory bowel disease, as bowel surveillance is important.
- Bring a list of your medicines and details of any previous scans, ERCPs or biopsies.
- Describe your symptoms clearly, especially itching, tiredness, fevers or weight loss.
- Ask how often you will need imaging (such as MRCP) and bowel surveillance.
- Ask how your bone health and fat-soluble vitamin levels will be checked.
- If an ERCP is planned, arrange transport home and follow fasting and sedation instructions.
- Keep alcohol low to avoid adding to liver strain.
What happens
PSC is usually diagnosed by a liver specialist using blood tests and imaging of the bile ducts, most often MRCP (a special MRI). Sometimes a liver biopsy is done. Many people are diagnosed after abnormal blood tests, particularly those known to have ulcerative colitis or Crohn's disease.
Because there is no proven medicine to stop PSC, care is built around regular monitoring: blood tests, imaging, and surveillance for bile duct, bowel and gallbladder cancers. People with inflammatory bowel disease usually have regular colonoscopies.
Symptoms are treated in their own right, and complications are dealt with as they arise. A dominant narrowing of a bile duct may be opened with an ERCP, and bile duct infections are treated promptly. Over time, some people are referred for liver transplant assessment.
Is this treatment right for me?
A good consultation should explore whether it's the right choice for you now — including reasons to wait or consider something else.
May not be suitable if…
- High-dose ursodeoxycholic acid is not recommended as routine treatment for PSC, and high doses have been linked to harm.
- There is no medicine that reliably stops PSC, so 'disease-curing' drug treatment is not an option outside research.
- ERCP is not a routine test for everyone; it is used when there is a blockage or concern, because it carries risks.
- Supplements and 'liver detox' products do not treat PSC and may be harmful.
Delay or rearrange if…
- You have a current bile duct infection (cholangitis) that needs treating urgently first.
- You are acutely unwell or jaundiced and need urgent assessment rather than routine clinic care.
- Key imaging to map the bile ducts has not yet been done.
- An ERCP is being considered without a clear indication; the need should be reviewed first.
Alternatives to discuss
- Surveillance and symptom-focused care, since no medicine reliably slows the disease.
- NHS specialist liver-centre care as an alternative to private pathways.
- Endoscopic treatment (ERCP) for specific blockages rather than ongoing drug treatment.
- Liver transplant assessment for advanced disease or severe complications.
Before you decide
Use this as a shared-decision checklist. The aim is not just “can this be done?”, but whether it is right for you, now, with the risks and alternatives clearly understood.
What matters most to me?
Think about symptoms, daily life, work, caring responsibilities, sport, fertility, travel, appearance and anxiety — the right choice depends on your priorities, not just the medical facts.
What are all my options?
Ask about waiting, monitoring, medicines, rehabilitation, a smaller or larger procedure, a different test, NHS referral, or a second opinion where that would help.
What would make me pause?
Active infection, pregnancy, unstable medical problems, smoking, medicines that increase bleeding, poor support at home, or feeling pressured are all reasons to slow down and get tailored advice.
What happens if I do nothing today?
For some problems, waiting is safe; for others, delay can make treatment harder. A good consultation should explain the trade-off in plain English.
Benefits
- Regular surveillance can catch bile duct, bowel or gallbladder cancer earlier.
- Symptoms such as itching and tiredness can often be eased.
- Opening a blocked bile duct (ERCP) can relieve symptoms and prevent infection.
- Prompt treatment of bile duct infections reduces the risk of serious illness.
- Monitoring helps time a liver transplant assessment appropriately for those who need it.
Risks & complications
- Itching and fatigue that can be hard to control fully
- Needing regular blood tests, imaging and (with colitis) colonoscopies for life
- Uncertainty, because the disease course varies widely between people
- Reduced absorption of fat-soluble vitamins and effects on bone strength
- Episodes of bile duct infection (cholangitis) with fever and pain
- A dominant bile duct narrowing needing an ERCP, which carries its own risks
- Progression to cirrhosis over years
- Need for repeated procedures over time
- Bile duct cancer (cholangiocarcinoma), a serious complication
- Gallbladder cancer, which is why the gallbladder is watched
- Advanced liver disease needing transplant
- Recurrence of PSC in a transplanted liver
The hardest parts of PSC are that no medicine is proven to stop it, and that it raises the risk of bile duct and bowel cancer. This makes surveillance, and prompt investigation of any new narrowing, weight loss or worsening blood tests, very important. Ask how often you need imaging and colonoscopy, and what the plan is if a complication develops.
Published figures to discuss
PSC varies widely, and several risks are well enough studied to give cautious ranges. These come from UK and international guidelines and are population figures, not predictions for any individual; your specialist can put them in context for you.
| Figure | Reported range | How to interpret it | Source / confidence |
|---|---|---|---|
| Bile duct cancer (cholangiocarcinoma) | About 0.6-1.5% per year; lifetime risk up to about 20% | BSG/UK-PSC guideline; about half of these cancers are found within a year of PSC diagnosis, which is why surveillance matters. | British Society of Gastroenterology (BSG) & UK-PSC - UK national guideline for the diagnosis and management of PSC (2019; full text via PMC)pmc.ncbi.nlm.nih.govPublished figure |
| Inflammatory bowel disease in people with PSC | Around 62-83% in those of Northern European descent | BSG/UK-PSC guideline; rates are lower in some other populations. Colitis raises bowel-cancer risk, so colonoscopy surveillance is advised. | British Society of Gastroenterology (BSG) & UK-PSC - UK national guideline for the diagnosis and management of PSC (2019; full text via PMC)pmc.ncbi.nlm.nih.govPublished figure |
| PSC returning after liver transplant | About 10-40% of transplanted patients | Review data; a transplant can cure the liver disease but PSC can recur in the new liver. | Transplantation for PSC: outcomes and recurrence - review (PMC)pmc.ncbi.nlm.nih.govPublished figure |
These are literature figures, not a personalised prediction. Your own risks and likely benefits depend on your circumstances, your health, and how your care is carried out and followed up.
What happens afterwards
There is no single recovery point, because this is long-term care. "Afterwards" means an ongoing programme of monitoring and surveillance, with treatment of symptoms and complications as they arise.
- Feeling well for long periods, especially early on
- Itching and fatigue that may come and go and need treatment
- Needing ongoing tests and scans rather than a one-off treatment
- Living with some uncertainty about how the disease will progress
Aftercare
- Attend all monitoring blood tests, scans and (if you have colitis) colonoscopies.
- Report new or worsening itching, fevers, weight loss or jaundice promptly.
- Take any prescribed medicines for symptoms as directed.
- Follow advice on bone protection and fat-soluble vitamins.
- Keep alcohol low and look after general liver and bowel health.
- Keep up recommended vaccinations and general health checks.
- Know who to contact, and when to seek urgent help, if warning signs appear.
- Surveillance plan written down (blood tests, MRCP, colonoscopy)
- Specialist liver-centre contact saved
- Itch and fatigue treatments discussed if needed
- Bone-health and vitamin monitoring arranged
- Clear list of warning signs and who to call out of hours
- If ERCP planned: transport, fasting and sedation arrangements made
⚠ Get urgent help if…
- Fever, shivering and tummy pain (possible bile duct infection) - seek urgent help
- Yellowing of the skin or eyes (jaundice) that is new or worsening
- Unexplained weight loss or worsening tiredness
- Severe, unrelenting itching
- New confusion, drowsiness or marked swelling of the tummy or legs
- Vomiting blood or passing black, tarry stools - call 999
Who to contact: your clinician, clinic or test provider first (keep their number to hand). For urgent advice when you can't reach them, call NHS 111. In an emergency, call 999.
General guidance — it doesn't replace the specific advice your specialist gives you.
Results & realistic expectations
There is no single "result" in PSC care. A good outcome means symptoms kept manageable, complications caught and treated early, and the disease monitored closely over time. For some people PSC progresses slowly over many years.
What care cannot currently do is stop or reverse the disease with medicine, or remove the raised risk of bile duct and bowel cancer. That is why surveillance is central, and why a liver transplant, the only cure for the liver disease, is considered for those who need it, even though PSC can sometimes return afterwards.
PSC varies greatly between people: some remain stable for many years, while others progress more quickly. Because there is no proven disease-slowing medicine, the focus is on long-term surveillance and timely treatment of complications. The plan is reviewed regularly, and transplant assessment is considered as the liver disease advances.
Related tests, treatments or support
PSC care is closely coordinated with management of inflammatory bowel disease, including regular bowel-cancer surveillance. Bone health and fat-soluble vitamins are managed alongside. If there are overlapping features with autoimmune hepatitis, treatment is tailored to the combined picture.
Follow-up & long-term care
Follow-up is lifelong, usually shared with a specialist liver centre. It includes regular blood tests and imaging (such as MRCP), surveillance for bile duct and gallbladder cancer, and, for those with inflammatory bowel disease, regular colonoscopy. People with advanced disease are reviewed for transplant assessment.
- Lifelong monitoring with blood tests and bile duct imaging (often MRCP)
- Bowel-cancer surveillance (colonoscopy) for those with inflammatory bowel disease
- Surveillance for bile duct and gallbladder cancer
- Treatment of symptoms such as itching and fatigue as needed
- Bone-health and fat-soluble vitamin monitoring
- Transplant assessment as the disease advances
Repeat, follow-on and what comes next
- Care is adjusted over time as the disease and symptoms change; there is no fixed regimen.
- ERCP may need repeating if narrowings recur, and stents may need changing.
- Some people move from monitoring to transplant assessment as the liver disease advances.
Ask what happens if the result is unclear or needs repeating, and what is included if further tests or follow-up are needed.
What good aftercare looks like
- A clear, written surveillance plan covering blood tests, bile duct imaging and (with colitis) colonoscopy.
- Prompt access to assessment and antibiotics for suspected bile duct infection.
- Active treatment of itching and fatigue, plus bone and vitamin monitoring.
- A named contact at a specialist liver centre and clear urgent-warning advice.
- Timely referral for transplant assessment when the disease advances.
What affects the cost
Costs vary a great deal between people and providers, and we don't publish prices. What matters is understanding what drives the cost and making sure your quote is complete. The main things that affect it:
- Specialist consultations, often in a liver centre, and how often you are reviewed
- Imaging of the bile ducts (such as MRCP) and how frequently it is needed
- Colonoscopy surveillance if you have inflammatory bowel disease
- Procedures such as ERCP, including sedation and any stents
- Treatments for symptoms and for bile duct infections
- Bone-health and vitamin monitoring, and transplant assessment if needed
- The specialist's consultation and follow-up fees
- Costs of imaging (MRCP) and how often it is needed
- Whether colonoscopy surveillance is included if you have colitis
- The cost of any ERCP, including sedation and stents
- Whether symptom treatments and infection care are covered
- What happens, and who pays, if a complication or cancer is found
On the NHS? Primary sclerosing cholangitis is routinely managed on the NHS, often in specialist liver centres, including ERCP and transplant assessment; private care is mainly used for speed, choice of clinician or a second opinion.
You're entitled to your total cost in writing — including reports, follow-up and what happens if the result is inconclusive — before you decide.
Consent traps and marketing red flags
These are not small details. They are often where patients lose choice, time to reflect, or realistic expectations.
Consent traps
- Being offered a medicine implied to stop PSC, when none is proven to do so.
- Being given high-dose ursodeoxycholic acid without explaining the evidence of possible harm.
- No clear surveillance plan for bile duct, gallbladder and bowel cancer.
- ERCP done without explaining its risks or the alternative of monitoring.
- Bone health and fat-soluble vitamins not monitored.
Marketing red flags
- Claims that a drug, supplement or diet can cure or reverse PSC.
- Offering ERCP or other procedures without a clear clinical reason.
- No mention of cancer surveillance or the link with bowel disease.
- Promising certainty about the course of a variable, unpredictable disease.
Choosing a specialist safely
- Check the specialist is on the GMC Specialist Register for this area.
- Make sure they work at a CQC-registered service, and look for membership of the relevant Royal College or professional body.
- You're entitled to time to consider and to have your questions answered before you agree — the specialist who looks after you should explain it, not a salesperson.
- Be wary of pressure: time-limited offers or deposits taken before you've had time to think are red flags, not bargains.
- You're entitled to your total cost in writing — including any follow-up — before you decide.
Questions to ask your medical professional
Take this to your consultation. A good specialist will welcome every one of these.
- How advanced is my PSC, and is there any scarring (cirrhosis) already?
- How often will I need bile duct imaging, and do I need bowel-cancer surveillance?
- What symptoms or changes should make me contact you urgently?
- What is the plan if a bile duct becomes narrowed or infected?
- How will my bone health and vitamin levels be monitored?
- At what point would a liver transplant be considered for me?
- Are you on the GMC Specialist Register for this area, and which Royal College or professional body are you a member of?
- Will you be the specialist who carries out my treatment, and who looks after me afterwards?
- What are the risks for someone like me, and how often do your own patients have a problem or need it repeated or redone?
- What does a realistic result look like — and what can this treatment not achieve?
- What are my options, including waiting, doing nothing for now, or choosing a different approach?
- Can I have written information, results and aftercare instructions in a format I can use, including any accessibility or communication support I need?
- What is the total cost in writing, including any follow-ups, and how much time do I have to decide?
Frequently asked questions
Is there a medicine that stops PSC?
What is the link with ulcerative colitis?
Why do I need so many scans and colonoscopies?
What is an ERCP and will I need one?
Will I need a liver transplant?
Is this treated on the NHS?
What national guidance does UK PSC care follow?
Find a verified specialist for primary sclerosing cholangitis (psc) care
Every consultant is GMC-checked and independently reviewed. Search by postcode and distance, or switch to a map. Ordered by rating, relevance and recency — never by who pays.
No verified consultants list this procedure yet — browse the full directory.
How we made this page
Medically reviewed by a GMC-registered consultant. Written in plain English, checked against NHS, NICE, GMC and relevant Royal College / specialist-society guidance, and kept under review. No clinic paid to appear on this page, and we publish no pricing. This is general information to help you prepare — it is not a substitute for advice from your own clinician. How we review our guides →
Source hierarchy: UK regulator and NHS/NICE guidance first, then relevant Royal College or specialist-society guidance, then peer-reviewed evidence for procedure-specific figures where available.
Sources & standards: British Liver Trust - Primary sclerosing cholangitis (PSC) British Society of Gastroenterology (BSG) & UK-PSC - UK national guideline for the diagnosis and management of PSC (2019; full text via PMC) PSC - StatPearls (NCBI Bookshelf) Transplantation for PSC: outcomes and recurrence - review (PMC) British Society of Gastroenterology (BSG) - PSC clinical resource / UK national guideline (2019)
Reviews reflect patients' experience of care, not clinical outcomes. For procedure volumes and outcome data see PHIN.
Last medically reviewed 2026-09-21. Spotted something wrong or out of date? Report an error in this guide.
Related guides: Autoimmune hepatitis care · Primary biliary cholangitis (PBC) care · Alcohol-related liver disease care · Cirrhosis management and monitoring · Haemochromatosis (iron overload) management